11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Systematic review of statistical methods used in molecular marker studies in cancer
(
- Contribution to journal › Article
- 2007
-
Mark
Prostataspecifikt antigen--den viktigaste cancermarkören. Diagnostik och uppföljning av prostatacancer har förändrats markant.
(
- Contribution to journal › Article
- 2006
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
(
- Contribution to journal › Article
- 2005
-
Mark
LD-isoenzym i uterusaspirat potentiell markör för endometriecancer. Utredning av postmenopausal blödning kan bli enklare och billigare
(
- Contribution to journal › Article
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
(
- Contribution to journal › Article
- 2003
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
- 2002
-
Mark
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
(
- Contribution to journal › Article
-
Mark
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
(
- Contribution to journal › Article
- 2001
-
Mark
The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease
(
- Contribution to journal › Article
- 1999
-
Mark
Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA
(
- Contribution to journal › Article